News Briefs: MAKO Purchase; KCI Merger; Medicare Competitive Bidding Update
This article was originally published in The Gray Sheet
Executive Summary
MAKO plans to acquire Pipeline Biomedical Holdings before it becomes part of Stryker. KCI, LifeCell and Systagenix to merge. Medicare announces rates for DME competitive bidding recompete. More news.
You may also be interested in...
News Briefs: Vertebral Augmentation Alternative; ReCor Recommits To Renal Denerv
Benvenue cleared for vertebral augmentation alternative. ReCor recommits to renal denervation. Spine surgery firm plans IPO. More news.
Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding
Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.
Reimbursement Briefs: TAVR Trial; Competitive Bidding Suppliers; OIG, GAO Reports
CMS approves coverage for Direct Flow TAVR study and announces durable medical equipment competitive bidding suppliers; OIG uncovers inappropriate payments for durable medical equipment. More reimbursement news.